Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice.

Tang JY, Aszterbaum M, Athar M, Barsanti F, Cappola C, Estevez N, Hebert J, Hwang J, Khaimskiy Y, Kim A, Lu Y, So PL, Tang X, Kohn MA, McCulloch CE, Kopelovich L, Bickers DR, Epstein EH Jr.

Cancer Prev Res (Phila). 2010 Jan;3(1):25-34. doi: 10.1158/1940-6207.CAPR-09-0200.

2.

Translating cyclooxygenase signaling in patch heterozygote mice into a randomized clinical trial in basal cell carcinoma.

Arbiser JL.

Cancer Prev Res (Phila). 2010 Jan;3(1):4-7. doi: 10.1158/1940-6207.CAPR-09-0246. Review.

3.

Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence.

Müller-Decker K.

Cancer Metastasis Rev. 2011 Dec;30(3-4):343-61. doi: 10.1007/s10555-011-9306-z. Review.

PMID:
22038018
4.

Genetics of basal cell carcinoma.

de Zwaan SE, Haass NK.

Australas J Dermatol. 2010 May;51(2):81-92; quiz 93-4. doi: 10.1111/j.1440-0960.2009.00579.x. Review.

PMID:
20546211
5.

Ptc1 heterozygous knockout mice as a model of multi-organ tumorigenesis.

Pazzaglia S.

Cancer Lett. 2006 Mar 28;234(2):124-34. Review.

PMID:
15925443
6.

Basal cell carcinomas: attack of the hedgehog.

Epstein EH.

Nat Rev Cancer. 2008 Oct;8(10):743-54. doi: 10.1038/nrc2503. Review.

7.
8.

Basal cell carcinoma and the carcinogenic role of aberrant Hedgehog signaling.

Saran A.

Future Oncol. 2010 Jun;6(6):1003-14. doi: 10.2217/fon.10.49. Review.

PMID:
20528237
9.

Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms.

Lacour JP.

Br J Dermatol. 2002 Apr;146 Suppl 61:17-9. Review.

PMID:
11966727
10.

Celecoxib, NSAIDs and the skeleton.

O'Connor JP, Lysz T.

Drugs Today (Barc). 2008 Sep;44(9):693-709. doi: 10.1358/dot.2008.44.9.1251573. Review.

PMID:
19137124
11.

Developmental genes and cancer: role of patched in basal cell carcinoma of the skin.

Gailani MR, Bale AE.

J Natl Cancer Inst. 1997 Aug 6;89(15):1103-9. Review.

PMID:
9262247
12.

Chemopreventive opportunities to control basal cell carcinoma: Current perspectives.

Tilley C, Deep G, Agarwal R.

Mol Carcinog. 2015 Sep;54(9):688-97. doi: 10.1002/mc.22348. Review.

PMID:
26053157
13.

Novel investigational drugs for basal cell carcinoma.

So PL, Tang JY, Epstein EH.

Expert Opin Investig Drugs. 2010 Sep;19(9):1099-112. doi: 10.1517/13543784.2010.504714. Review.

Items per page

Supplemental Content

Support Center